Detalhe da pesquisa
1.
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 25(7): 922-932, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38936379
2.
Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study.
Br J Cancer
; 129(11): 1780-1786, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813959
3.
Endoscope-assisted microsurgical resection of a third ventricular immature teratoma.
Childs Nerv Syst
; 39(12): 3435-3443, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37401973
4.
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.
BMC Cancer
; 22(1): 652, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698215
5.
First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma.
J Pediatr Hematol Oncol
; 44(6): e948-e953, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622995
6.
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma.
J Neurooncol
; 147(3): 577-585, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32246395
7.
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells.
Mol Ther
; 27(5): 933-946, 2019 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879952
8.
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study.
BMC Pediatr
; 20(1): 48, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005112
9.
Implementation eines telemedizinischen Dringlichkeitseinschätzung-Verfahrens in der pädiatrischen Notaufnahme - Evaluationsergebnisse.
Gesundheitswesen
; 2024 May 13.
Artigo
em Alemão
| MEDLINE | ID: mdl-38740378
10.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1617-1629, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442501
11.
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.
Biol Blood Marrow Transplant
; 24(5): 1005-1012, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307718
12.
Inflammatory response and treatment tolerance of long-term infusion of the anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastoma.
Pediatr Blood Cancer
; 65(6): e26967, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29350486
13.
Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?
Eur J Nucl Med Mol Imaging
; 44(13): 2203-2212, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28808732
14.
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.
Klin Padiatr
; 229(3): 147-167, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28561228
15.
Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma.
Int J Cancer
; 138(8): 2030-42, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26595750
16.
Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.
Cancer Immunol Immunother
; 64(5): 621-34, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25711293
17.
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
Cancer Immunol Immunother
; 64(10): 1215-27, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076666
18.
Development of immunomonitoring of antibodydependent cellular cytotoxicity against neuroblastoma cells using whole blood.
Cancer Immunol Immunother
; 63(6): 559-69, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658837
19.
Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study.
BMC Pregnancy Childbirth
; 14: 75, 2014 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552439
20.
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.
Bone Marrow Transplant
; 59(5): 587-596, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326567